Science
Mechanism of Action
This extract modulates the skin's inflammatory response by inhibiting NF-κB and MAPK signaling pathways, effectively suppressing the secretion of pro-inflammatory cytokines like TNF-α and IL-6. Its therapeutic profile is driven by bisabolol and chamazulene for immediate soothing, while the flavonoids apigenin and luteolin provide a robust defense against oxidative environmental stress.
Research
Clinical Evidence
High confidence5%
Key findings
- 01 A 2% ethanolic extract demonstrated efficacy comparable to 0.25% hydrocortisone in managing atopic eczema maintenance therapy.
- 02 An 8.35% concentration significantly delayed Grade 2 radiation dermatitis and reduced associated burning sensations.
- 03 Dose-dependent wound healing studies identified 5% as the optimal concentration for accelerating closure during inflammatory phases.
Transparency
Dusting Analysis
While clinically validated at 2-5% for inflammatory conditions, commercial leave-on formulations frequently 'dust' this ingredient at 0.1% or lower for marketing claims. To achieve the hydrocortisone-mimicking results seen in clinical data, concentrations should ideally reach or exceed 2%.
The Formula
Formulation
Stability
Highly thermolabile; must be incorporated during the cooling phase (below 40°C) to preserve volatile constituents and bioactivity. Flavonoids remain stable between pH 5.0 and 7.0.
Synergies
- Bisabolol
- Urea
- Antioxidants
Conflicts
- Strong oxidizing agents
- Alkaline environments (pH > 8.0)
- High processing temperatures
Safety
Safety Profile
Generally recognized as safe by the CIR Expert Panel. However, individuals with known allergies to the Asteraceae (Compositae) family should exercise caution due to potential cross-reactivity.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A gold-standard botanical for reactive skin that, when used at therapeutic levels (≥2%), offers anti-inflammatory benefits rivaling mild topical steroids.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources